BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38714204)

  • 1. Management, Utilization, and Outcomes of Preterm Labor in an Integrated Health Care System.
    Getahun D; Sacks DA; Shi J; Xie F; Khadka N; Chiu VY; Mensah NA; Avila CC; Yeh M; Kawatkar AA; Ruma MS; Joyce D; Fassett MJ
    Am J Perinatol; 2024 May; ():. PubMed ID: 38714204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Preterm Labor Evaluation Visits and Extraction of Cervical Length Measures from Electronic Health Records Within a Large Integrated Health Care System: Algorithm Development and Validation.
    Xie F; Khadka N; Fassett MJ; Chiu VY; Avila CC; Shi J; Yeh M; Kawatkar A; Mensah NA; Sacks DA; Getahun D
    JMIR Med Inform; 2022 Sep; 10(9):e37896. PubMed ID: 36066930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study
    Levine LD; Downes KL; Romero JA; Pappas H; Elovitz MA
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3792-3800. PubMed ID: 29727248
    [No Abstract]   [Full Text] [Related]  

  • 4. Fetal fibronectin testing and pregnancy outcomes among Texas Medicaid patients at risk for preterm birth.
    Barner JC; Petrilla AA; Kang HA; Shen X; Alshehri AM; Sullivan EM; Troeger KA; Richards KM; Blackwell SC
    Am J Manag Care; 2017 Dec; 23(19 Suppl):S363-S370. PubMed ID: 29297659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease in the incidence of threatened preterm labor after implementation of transvaginal ultrasound cervical length universal screening.
    Navathe R; Saccone G; Villani M; Knapp J; Cruz Y; Boelig R; Roman A; Berghella V
    J Matern Fetal Neonatal Med; 2019 Jun; 32(11):1853-1858. PubMed ID: 29303014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal fibronectin testing for reducing the risk of preterm birth.
    Berghella V; Saccone G
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD006843. PubMed ID: 31356681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined fetal fibronectin and cervical length and spontaneous preterm birth in asymptomatic triplet pregnancies.
    Fox NS; Rebarber A; Roman AS; Klauser CK; Peress D; Saltzman DH
    J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2308-11. PubMed ID: 22563765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of quantitative fetal fibronectin for spontaneous preterm birth in asymptomatic pregnancies: a systematic literature review and meta-analysis.
    Ruma MS; Betts M; Dodman S; Neupane B
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2279923. PubMed ID: 37953268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of fetal fibronectin testing and pregnancy outcomes among women with symptoms of preterm labor.
    Blackwell SC; Sullivan EM; Petrilla AA; Shen X; Troeger KA; Byrne JD
    Clinicoecon Outcomes Res; 2017; 9():585-594. PubMed ID: 29042802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between fetal fibronectin and spontaneous preterm birth in twin pregnancies with a shortened cervical length
    Matthews KC; Gupta S; Lam-Rachlin J; Saltzman DH; Rebarber A; Fox NS
    J Matern Fetal Neonatal Med; 2018 Oct; 31(19):2564-2568. PubMed ID: 28651447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
    Melchor JC; Khalil A; Wing D; Schleussner E; Surbek D
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Availability and use of fetal fibronectin testing and transvaginal ultrasound for preterm labor evaluation in the United States.
    Ruma MS; Banker WM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8586-8593. PubMed ID: 34648390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of quantitative ultrasound tissue characterization of the cervix and rapid fetal fibronectin in predicting preterm delivery.
    Tekesin I; Wallwiener D; Schmidt S
    J Perinat Med; 2005; 33(5):383-91. PubMed ID: 16238532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous preterm birth as a function of normal cervical length in low-risk women.
    Dunn TN; Becker DA; Szychowski JM; Owen J
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9978-9982. PubMed ID: 35638871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women.
    Bruijn M; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers H; Spaanderman M; Bloemenkamp K; Haak MC; Bolte AC; Vandenbussche F; Woiski MD; Bax CJ; Cornette J; Duvekot JJ; Nij Bijvanck B; van Eyck J; Franssen M; Sollie KM; van der Post J; Bossuyt P; Opmeer BC; Kok M; Mol B; van Baaren GJ
    BJOG; 2016 Nov; 123(12):1965-1971. PubMed ID: 26667313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic high-risk women.
    Tran TL; Jwala S; Terenna C; McGregor A; Das A; Baxter JK; Berghella V
    J Matern Fetal Neonatal Med; 2020 Aug; 33(15):2628-2634. PubMed ID: 30612481
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis.
    Deshpande SN; van Asselt AD; Tomini F; Armstrong N; Allen A; Noake C; Khan K; Severens JL; Kleijnen J; Westwood ME
    Health Technol Assess; 2013 Sep; 17(40):1-138. PubMed ID: 24060096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.
    Ravi M; Beljorie M; El Masry K
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
    Jun SY; Lee JY; Kim HM; Kim MJ; Cha HH; Seong WJ
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):241. PubMed ID: 31296172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.